PYRROLIDINE DITHIOCARBAMATE DIFFERENTIALLY AFFECTS CYTOKINE-INDUCED AND CAMP-INDUCED EXPRESSION OF GROUP-II PHOSPHOLIPASE A(2) IN RAT RENAL MESANGIAL CELLS

被引:35
作者
WALKER, G
KUNZ, D
PIGNAT, W
VANDENBOSCH, H
PFEILSCHIFTER, J
机构
[1] UNIV BASEL,BIOZENTRUM,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND
[2] CIBA GEIGY AG,DEPT RES,DIV PHARMACEUT,CH-4002 BASEL,SWITZERLAND
[3] UNIV UTRECHT,CTR BIOMEMBRANES & LIPID ENZYMOL,3584 CH UTRECHT,NETHERLANDS
关键词
PHOSPHOLIPASE A(2); INTERLEUKIN-1; CYCLIC AMP; NUCLEAR FACTOR B; MESANGIAL CELL;
D O I
10.1016/0014-5793(95)00402-U
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Renal mesangial cells express group II phospholipase A(2) in response to two principal classes of activating signals that may interact in a synergistic fashion, These two groups of activators comprise inflammatory cytokines such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) and agents that elevate cellular levels of cAMP such as forskolin, an activator of adenylate cyclase, Using pyrrolidine dithiocarbamate (PDTC), a potent inhibitor of nuclear factor NF kappa B, we determined its role in cytokine - and cAMP - triggered group II PLA(2) expression, Micromolar amounts of PDTC suppress the IL-1 beta- and TNF alpha-dependent, but not the forskolin-stimulated group II PLA(2) activity in mesangial cells, Furthermore, PDTC inhibited the increase of group II PLA(2) mRNA steady state levels in response to IL-1 beta and TNF alpha, while only marginally affecting forskolin-induced PLA(2) mRNA levels, Our data suggest that NF kappa B activation is an essential component of the cytokine signalling pathway responsible for group II PLA(2) gene regulation and that cAMP triggers a separate signalling cascade not involving NF kappa B. These observations may provide a basis to study the underlying mechanisms involved in the regulation of group II PLA(2) gene expression.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 31 条
[1]   FUNCTION AMD ACTIVATION OF NF-KAPPA-B IN THE IMMUNE-SYSTEM [J].
BAEUERLE, PA ;
HENKEL, T .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :141-179
[2]  
CHANG J, 1986, J IMMUNOL, V136, P1283
[3]  
CROWL RM, 1991, J BIOL CHEM, V266, P2647
[4]   PHOSPHOLIPASE-A2 ENZYMES - REGULATION AND INHIBITION [J].
GLASER, KB ;
MOBILIO, D ;
CHANG, JY ;
SENKO, N .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (03) :92-98
[5]   RECOMBINANT TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 BOTH STIMULATE HUMAN SYNOVIAL CELL ARACHIDONIC-ACID RELEASE AND PHOSPHOLIPID-METABOLISM [J].
GODFREY, RW ;
JOHNSON, WJ ;
HOFFSTEIN, ST .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) :235-241
[6]  
HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913
[7]  
KERR J, 1989, BIOCHEM BIOPH RES CO, V165, P1097
[8]   STRUCTURE OF GENE CODING FOR RAT GROUP-II PHOSPHOLIPASE-A2 [J].
KOMADA, M ;
KUDO, I ;
INOUE, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1059-1065
[9]   STRUCTURE OF GENOMIC DNA FOR RAT PLATELET PHOSPHOLIPASE-A2 [J].
KUSUNOKI, C ;
SATOH, S ;
KOBAYASHI, M ;
NIWA, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1087 (01) :95-97
[10]   INTERLEUKIN-1-STIMULATION AND TUMOR NECROSIS FACTOR-STIMULATION OF PROSTAGLANDIN-E2 SYNTHESIS IN MDCK CELLS, AND POTENTIATION OF THIS EFFECT BY CYCLOHEXIMIDE [J].
LEIGHTON, JD ;
PFEILSCHIFTER, J .
FEBS LETTERS, 1990, 259 (02) :289-292